FDA
approval
· 2025-12-29
FDA Approved: POMALIDOMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
The FDA approved a supplemental application for Camber Pharmaceuticals’ pomalidomide, providing a generic version of pomalidomide under the approved labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for POMALIDOMIDE (POMALIDOMIDE)